Eliquis Recall Over Mislabeling Prompts Dosage Concerns
Bristol-Myers Squibb has issued a voluntary recall relating to Eliquis, the company's blockbuster blood-thinning drug. The lot in question has been recalled due to an incorrectly printed label stating the package contains 5 mg tablets. Its actual content is half that…